enhancing outcomes of patients with dlbcl treated with car t-cell therapy
Published 4 months ago • 70 plays • Length 0:32Download video MP4
Download video MP3
Similar videos
-
1:06
car-t cell therapy: current applications and how to improve treatment strategies in the future
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
3:21
safety management of car-t cell therapy in dlbcl
-
3:05
car-t therapy in r/r dlbcl
-
2:10
optimizing car-t therapy in lbcl
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
3:59
strategies to improve car t-cell manufacturing
-
1:33
patient selection for car-t in all
-
4:16
car t-cell therapy
-
4:20
utilizing neoantigen-specific tcrs for personalized immunotherapies
-
![simplifying gmp car t and car nk cell therapy manufacturing processes [webinar]](https://i.ytimg.com/vi/OThRND_fNRc/mqdefault.jpg)
1:04:15
simplifying gmp car t and car nk cell therapy manufacturing processes [webinar]
-
1:02
the use of car-t cell products in a real-world setting
-
1:29
improving access to car-t therapy by reducing turnaround time
-
2:02
improving t-cell therapy with antigen specific t-cells
-
1:06
manufacturing strategies to improve car t-cell persistence
-
0:50
improving car-t cell efficacy: optimizing car constructs and counteracting tumor escape
-
8:27
phase i trial of donor-derived cd7 car t-cells for t-all
-
1:43
cd33-tim3 dual car t-cells enhance specificity of aml treatment
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
3:56
considerations and challenges of integrating car-t and transplantation in b-all
-
8:27
anti cd7 car t-cell therapy in t-all
-
2:08
car t-cell therapy: co-operation could lead to unprecedented levels of efficacy